Kuros Biosciences Ag Stock Market Value

CSBTF Stock  USD 27.34  4.34  18.87%   
Kuros Biosciences' market value is the price at which a share of Kuros Biosciences trades on a public exchange. It measures the collective expectations of Kuros Biosciences AG investors about its performance. Kuros Biosciences is trading at 27.34 as of the 9th of January 2025. This is a 18.87 percent increase since the beginning of the trading day. The stock's lowest day price was 26.4.
With this module, you can estimate the performance of a buy and hold strategy of Kuros Biosciences AG and determine expected loss or profit from investing in Kuros Biosciences over a given investment horizon. Check out Kuros Biosciences Correlation, Kuros Biosciences Volatility and Kuros Biosciences Alpha and Beta module to complement your research on Kuros Biosciences.
Symbol

Please note, there is a significant difference between Kuros Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kuros Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kuros Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kuros Biosciences 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kuros Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kuros Biosciences.
0.00
12/10/2024
No Change 0.00  0.0 
In 31 days
01/09/2025
0.00
If you would invest  0.00  in Kuros Biosciences on December 10, 2024 and sell it all today you would earn a total of 0.00 from holding Kuros Biosciences AG or generate 0.0% return on investment in Kuros Biosciences over 30 days. Kuros Biosciences is related to or competes with Abbott Laboratories, Stryker, Edwards Lifesciences, Boston Scientific, and DexCom. Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical... More

Kuros Biosciences Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kuros Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kuros Biosciences AG upside and downside potential and time the market with a certain degree of confidence.

Kuros Biosciences Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kuros Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kuros Biosciences' standard deviation. In reality, there are many statistical measures that can use Kuros Biosciences historical prices to predict the future Kuros Biosciences' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kuros Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
21.9227.3432.76
Details
Intrinsic
Valuation
LowRealHigh
22.7028.1233.54
Details

Kuros Biosciences Backtested Returns

Kuros Biosciences appears to be not too volatile, given 3 months investment horizon. Kuros Biosciences has Sharpe Ratio of 0.0898, which conveys that the firm had a 0.0898% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Kuros Biosciences, which you can use to evaluate the volatility of the firm. Please exercise Kuros Biosciences' Mean Deviation of 2.85, risk adjusted performance of 0.0671, and Downside Deviation of 8.01 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kuros Biosciences holds a performance score of 7. The company secures a Beta (Market Risk) of 0.29, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kuros Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Kuros Biosciences is expected to be smaller as well. Please check Kuros Biosciences' treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Kuros Biosciences' current price movements will revert.

Auto-correlation

    
  -0.23  

Weak reverse predictability

Kuros Biosciences AG has weak reverse predictability. Overlapping area represents the amount of predictability between Kuros Biosciences time series from 10th of December 2024 to 25th of December 2024 and 25th of December 2024 to 9th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kuros Biosciences price movement. The serial correlation of -0.23 indicates that over 23.0% of current Kuros Biosciences price fluctuation can be explain by its past prices.
Correlation Coefficient-0.23
Spearman Rank Test0.42
Residual Average0.0
Price Variance3.33

Kuros Biosciences lagged returns against current returns

Autocorrelation, which is Kuros Biosciences pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kuros Biosciences' pink sheet expected returns. We can calculate the autocorrelation of Kuros Biosciences returns to help us make a trade decision. For example, suppose you find that Kuros Biosciences has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Kuros Biosciences regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kuros Biosciences pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kuros Biosciences pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kuros Biosciences pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Kuros Biosciences Lagged Returns

When evaluating Kuros Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kuros Biosciences pink sheet have on its future price. Kuros Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kuros Biosciences autocorrelation shows the relationship between Kuros Biosciences pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Kuros Biosciences AG.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Kuros Pink Sheet

Kuros Biosciences financial ratios help investors to determine whether Kuros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kuros with respect to the benefits of owning Kuros Biosciences security.